Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79347 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Sulconazole Related Compound A (1-[2-(4-Chlorobenzyl)sulfinyl-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C18H15Cl3N2OS·HNO3Color and Shape:PowderMolecular weight:474.99271Melamine (2,4,6-Triamino-1,3,5-triazine)
CAS:MelamineFormula:C3H6N6Color and Shape:White Crystalline PowderMolecular weight:126.065391,2-Dinitroglycerin
CAS:Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFormula:C3H6N2O7Color and Shape:Clear Colorless LiquidMolecular weight:182.0175Sodium Sulfate Anhydrous
CAS:Disodium sulfate, except salt cake, nesoiFormula:Na2SO4Color and Shape:White Crystalline Powder Crystalline GranulesMolecular weight:141.93127Gabapentin Related Compound D ([1-(3-Oxo-2-aza-spiro[4.5]dec-2-ylmethyl)cyclohexyl]acetic acid)
CAS:Lactams not elsewhere specified or includedFormula:C18H29NO3Color and Shape:White PowderMolecular weight:307.21474Brimonidine Related Compound A (5-Bromoquinoxalin-6-amine)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C8H6BrN3Color and Shape:Yellow Crystalline PowderMolecular weight:222.97451Pioglitazone Hydrochloride
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C19H20N2O3S·HClColor and Shape:White PowderMolecular weight:356.11946Benzalkonium Chloride (5 mL of approx. 4% aqueous solution)
CAS:<p>Cationic organic surface-active agents,other than aromatic or modified aromatic, whether or not for retail sale</p>Color and Shape:Clear Colorless LiquidCiprofloxacin Related Compound A (7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride salt)
<p>Compounds containing a pyrimidine ring (whether or not</p>Formula:C17H18N3O3Cl·HClColor and Shape:Pale Yellow PowderMolecular weight:384.26Gadoteridol Related Compound A (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid)
CAS:Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFormula:C17H32N4O7Color and Shape:White PowderMolecular weight:404.2271Chloroquine Related Compound E (N4-(5-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine oxalate)
Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFormula:C20H28ClN3O4Color and Shape:White SolidMolecular weight:409.17683Voriconazole Related Compound A ((2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H14F3N5OColor and Shape:Light Yellow PowderMolecular weight:349.11504Amoxicillin Related Compound C ((4S)-2-[5-(4-hydroxyphenyl)-3,6-dioxopiperazin-2-yl]-5,5-dimethylthiazolidine-4-carboxylic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C16H19N3O5SColor and Shape:White PowderMolecular weight:365.10454Procarbazine Related Compound A (4-Formyl-N-isopropylbenzamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C11H13NO2Color and Shape:White Yellow SolidMolecular weight:191.09463Fenoldopam Related Compound B (1-(4-Hydroxyphenyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol methanesulfonate)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C16H17NO3·CH4SO3Color and Shape:Off-White PowderMolecular weight:271.12084Fluorometholone Related Compound A (11β,17α-Dihydroxy-6α-methylpregna-1,4-diene-3,20-dione)
CAS:Ketone-alcohols and ketone-aldehydes, nesoiFormula:C22H30O4Color and Shape:White Off-White PowderMolecular weight:358.21441Ecamsule Related Compound F (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzoic acid)
CAS:Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormula:C18H20O6SColor and Shape:White PowderMolecular weight:364.09806Cyclosporine Resolution Mixture (This material is an approximate 100:1 (w/w) mixture of cyclosporine and cyclosporine U)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:White PowderGranisetron Related Compound D (1-Methyl-1H-indazole-3-carboxylic acid)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C9H8N2O2Color and Shape:Pale Yellow PowderMolecular weight:176.05858Bosentan Related Compound D (4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C15H10Cl2N4O2Color and Shape:Yellow PowderMolecular weight:348.01808
